A review of studies published during 1998 examining the treatment and management of benign prostatic obstruction
2000; Wiley; Volume: 85; Issue: s1 Linguagem: Inglês
10.1046/j.1464-410x.2000.00046.x
ISSN1464-410X
AutoresR. Frymann, David Cranston, P. O rsquo Boyle,
Tópico(s)Urological Disorders and Treatments
ResumoBJU InternationalVolume 85, Issue s1 p. 46-53 A review of studies published during 1998 examining the treatment and management of benign prostatic obstruction R. Frymann, R. Frymann Departments of Urology, Southmead Hospital, Bristol,Search for more papers by this authorD. Cranston, D. Cranston Churchill Hospital, Oxford, andSearch for more papers by this authorP. O’ Boyle, P. O’ Boyle Taunton and Somerset Hospital, Somerset, UKSearch for more papers by this author R. Frymann, R. Frymann Departments of Urology, Southmead Hospital, Bristol,Search for more papers by this authorD. Cranston, D. Cranston Churchill Hospital, Oxford, andSearch for more papers by this authorP. O’ Boyle, P. O’ Boyle Taunton and Somerset Hospital, Somerset, UKSearch for more papers by this author First published: 27 August 2008 https://doi.org/10.1046/j.1464-410x.2000.00046.xCitations: 2 R. Frymann, Department of Urology, Southmead Hospital, Bristol, UK. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Gallucci M, Puppo P, Perachino M et al. Transurethral electrovaporization of the prostate vs. transurethral resection. Results of a multicentric, randomized clinical study on 150 patients. Eur Urol 1998; 33: 359–64 10.1159/000019616 CASPubMedWeb of Science®Google Scholar 2 Kupeli S, Baltaci S, Soygur T, Aytac S, Yilmaz E, Budak M. A prospective randomized study of transurethral resection of the prostate and transurethral vaporization of the prostate as a therapeutic alternative in the management of men with BPH. Eur Urol 1998; 34: 15–8 10.1159/000019671 CASPubMedWeb of Science®Google Scholar 3 Hammadeh MY, Madaan S, Singh M, Philp T. Two-year follow-up of a prospective randomised trial of electrovaporization versus resection of prostate. Eur Urol 1998; 34: 188–92 10.1159/000019710 CASPubMedWeb of Science®Google Scholar 4 Hammadeh MY, Fowlis GA, Singh M, Philp T. Transurethral electrovaporization of the prostate - a possible alternative to transurethral resection: a one-year follow-up of a prospective randomized trial. Br J Urol 1998; 81: 721–5 10.1046/j.1464-410x.1998.00635.x CASPubMedWeb of Science®Google Scholar 5 D’Ancona FCH, Francisca AEA, Witjes WPJ, Welling L, Debruyne FMJ, De La Rosette JJMCH. Transurethral resection of the prostate vs. high-energy thermotherapy of the prostate in patients with benign prostatic hyperplasia: long-term results. Br J Urol 1998; 81: 259–64 10.1046/j.1464-410X.1998.00542.x CASPubMedWeb of Science®Google Scholar 6 Bruskewitz R, Issa MM, Roehrborn CG et al. A prospective, randomized 1-year clinical trial comparing transurethral needle ablation to transurethral resection of prostate for the treatment of symptomatic benign prostatic hyperplasia. J Urol 1998; 159: 1588–94 10.1097/00005392-199805000-00048 CASPubMedWeb of Science®Google Scholar 7 Jahnson S, Dalén M, Gustavsson G, Pedersen J. Transurethral incision versus resection of the prostate for small to medium benign prostatic hyperplasia. Br J Urol 1998; 81: 276–81 10.1046/j.1464-410X.1998.00535.x CASPubMedWeb of Science®Google Scholar 8 Larson TR, Blute ML, Bruskewitz RC, Utz WJ. A high-efficiency microwave thermoablation system for the treatment of benign prostatic hyperplasia: results of a randomized, sham-controlled, prospective, double-blind, multi- center clinical trial. Urology 1998; 51: 731–42 10.1016/S0090-4295(97)00710-3 CASPubMedWeb of Science®Google Scholar 9 Roehrborn CG, Preminger G, Newhall P, Womack S. Microwave thermotherapy for benign prostatic hyperplasia with the Dornier Urowave: results of a randomized, double-blind, multicenter, sham-controlled trial. Urology 1998; 51: 19–28 10.1016/S0090-4295(97)00571-2 PubMedGoogle Scholar 10 Flanigan RC, Reda DJ, Wasson JH, Anderson RJ, Abdellatif M, Bruskewitz RC. 5-Year outcome of surgical resection and watchful waiting for men with moderately symptomatic benign prostatic hyperplasia: a Department of Veterans Affairs Cooperative Study. J Urol 1998; 160: 12–7 10.1016/S0022-5347(01)63011-8 CASPubMedWeb of Science®Google Scholar 11 Gilling PJ, Cass CB, Malcolm A, Kabalin JN. Holmium laser resection of the prostate versus neodymium: yttrium-aluminium-garnet visual laser ablation of the prostate: a randomized prospective comparison of two techniques for laser prostatectomy. Urology 1998; 51: 573–7 10.1016/S0090-4295(97)00642-0 CASPubMedWeb of Science®Google Scholar 12 Ekman P. Maximum efficacy of finasteride is obtained within 6 months and maintained over 6 years. follow-up of the Scandinavian Open-Extension Study. Eur Urol 1998; 33: 312–7 10.1159/000019566 CASPubMedWeb of Science®Google Scholar 13 Marberger MJ, on behalf of the PROWESS Study Group. Long-term effects of finasteride in patients with benign prostatic hyperplasia: a double-blind, placebo-controlled, multicenter study. Urology 1998; 51: 677–86 10.1016/S0090-4295(98)00094-6 CASPubMedWeb of Science®Google Scholar 14 Lepor H, for the Tamsulosin Investigator Group. Long-term evaluation of tamsulosin in benign prostatic hyperplasia: placebo-controlled, double-blind extension of phase III trial. Urology 1998; 51: 901–6 10.1016/S0090-4295(98)00127-7 CASPubMedWeb of Science®Google Scholar 15 Debruyne FMJ, Jardin A, Colloi D et al. Sustained-release alfuzosin, finasteride and the combination of both in the treatment of benign prostatic hyperplasia. Eur Urol 1998; 34: 169–75 10.1159/000019706 CASPubMedWeb of Science®Google Scholar 16 Kaplan SA, Reis RB, Cologna A, Te AE. Intermittent alpha-blocker therapy in the treatment of men with lower urinary tract symptoms. Urology 1998; 52: 12–6 10.1016/S0090-4295(98)00158-7 CASPubMedWeb of Science®Google Scholar 17 Lepor H, Williford WO, Barry MJ, Haakenson C, Jones K, for the Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group. The impact of medical therapy on bother due to symptoms, quality of life and global outcome, and factors predicting response. J Urol 1998; 160: 1358–67 10.1016/S0022-5347(01)62536-9 CASPubMedWeb of Science®Google Scholar 18 Narayan P, Tewari A, and Members of United States 93 –01 Study Group. A second phase III multicenter placebo controlled study of 2 dosages of modified release tamsulosin in patients with symptoms of benign prostatic hyperplasia. J Urol 1998; 160: 1701–6 CASPubMedWeb of Science®Google Scholar 19 Reynard JM, Cannon A, Yang Q, Abrams P. A novel therapy for nocturnal polyuria: a double-blind randomized trial of frusemide against placebo. Br J Urol 1998; 81: 215–8 10.1046/j.1464-410X.1998.00511.x CASPubMedWeb of Science®Google Scholar 20 Scholz M, Luftenegger W, Harmuth H, Wolf D, Holtl W. Single-dose antibiotic prophylaxis in transurethral resection of the prostate: a prospective randomized trial. Br J Urol 1998; 81: 827–9 10.1046/j.1464-410x.1998.00655.x CASPubMedWeb of Science®Google Scholar 21 Djavan B, Shariat S, Schafer B, Marberger M. Tolerability of high energy transurethral microwave thermotherapy with topical urethral anesthesia: results of prospective, randomized, single-blinded clinical trial. J Urol 1998; 160: 772–6 10.1016/S0022-5347(01)62783-6 CASPubMedWeb of Science®Google Scholar 22 Hahn RG, Sandfeldt L, Nyman CR. Double-blind randomized study of symptoms associated with absorption of glycine 1.5% or mannitol 3% during transurethral resection of prostate. J Urol 1998; 160: 397–401 10.1016/S0022-5347(01)62907-0 CASPubMedWeb of Science®Google Scholar 23 Zwergel U, Wullich B, Lindermeir U, Rohde V, Zwergel T. Long-term results following transurethral resection of the prostate. Eur Urol 1998; 33: 476–80 10.1159/000019638 CASPubMedWeb of Science®Google Scholar 24 Gordon NSI. Catheter-free same day surgery transurethral resection of prostate. J Urol 1998; 160: 1709–12 10.1016/S0022-5347(01)62390-5 CASPubMedWeb of Science®Google Scholar 25 Glass JM, Bdesha AS, Witherow R.O’N. Microwave thermotherapy: a long-term follow-up of 67 patients from a single centre. Br J Urol 1998; 81: 377–82 10.1046/j.1464-410x.1998.00559.x CASPubMedWeb of Science®Google Scholar 26 Eliasson T, Damber JE, Teriö H. Pressure-flow studies before and after transurethral microwave thermotherapy of benign prostatic hyperplasia using low- and high-energy protocols. Br J Urol 1998; 82: 513–9 10.1046/j.1464-410X.1998.00770.x CASPubMedWeb of Science®Google Scholar 27 Lau KO, Li MK, Foo KT. Long-term follow-up of transurethral microwave thermotherapy. Urology 1998; 52: 829–33 10.1016/S0090-4295(98)00285-4 CASPubMedWeb of Science®Google Scholar 28 Stravodimos KG, Goldfischer ER, Klima WJ, Jabbour ME, Smith AD. Transurethral microwave thermotherapy for management of benign prostatic hyperplasia: a single-institution experience. Urology 1998; 51: 1008–12 10.1016/S0090-4295(98)00018-1 CASPubMedWeb of Science®Google Scholar 29 Eliasson T, Damber JE. Temperature controlled high energy transurethral microwave thermotherapy for benign prostatic hyperplasia using a heat shock strategy. J Urol 1998; 160: 777–82 10.1016/S0022-5347(01)62784-8 CASPubMedWeb of Science®Google Scholar 30 Keijzers GBJM, Francisca EAE, D’Ancona FCH, Kiemeney LALM, Debruyne FMJ, De La Rosette JJMCH . Long-term results of lower energy transurethral microwave thermotherapy. J Urol 1998; 159: 1966–73 10.1016/S0022-5347(01)63211-7 CASPubMedWeb of Science®Google Scholar 31 Larson TR, Collins JM, Corica A. Detailed interstitial temperature mapping during treatment with a novel transurethral microwave thermoablation system in patient with benign prostatic hyperplasia. J Urol 1998; 159: 258–64 10.1016/S0022-5347(01)64078-3 CASPubMedWeb of Science®Google Scholar 32 Wagrell L, Schelin S, Bolmsjo M, Brudin L. Intraprostatic temperature monitoring during transurethral microwave thermotherapy for the treatment of benign prostatic hyperplasia. J Urol 1998; 159: 1583–7 10.1097/00005392-199805000-00047 CASPubMedWeb of Science®Google Scholar 33 Kahn SA, Alphonse P, Tewari A, Narayan P. An open study on the efficacy and safety of transurethral needle ablation of the prostate in treating symptomatic benign prostatic hyperplasia: The University of Florida experience. J Urol 1998; 160: 1695–700 10.1016/S0022-5347(01)62385-1 CASPubMedWeb of Science®Google Scholar 34 Roehrborn CG, Issa MM, Bruskewitz RC, Narayan P. Transurethral needle ablation for benign prostatic hyperplasia: 12-month results of a prospective, multicenter US study. Urology 1998; 51: 415–21 10.1016/S0090-4295(97)00682-1 CASPubMedWeb of Science®Google Scholar 35 Neykov KG, Panchev P, Georgiev M. Late results after transurethral bladder neck incision. Eur Urol 1998; 33: 73–8 10.1159/000019514 CASPubMedWeb of Science®Google Scholar 36 Cornford PA, Biyani CS, Powell CS. Transurethral incision of the prostate using holmium:YAG. A catheterless procedure. J Urol 1998; 159: 1229–31 10.1016/S0022-5347(01)63566-3 CASPubMedWeb of Science®Google Scholar 37 Fraundorfer MR, Gilling PJ. Holmium:YAG laser enucleation of the prostate combined with mechanical morcellation: preliminary results. Eur Urol 1998; 33: 69–72 10.1159/000019535 CASPubMedWeb of Science®Google Scholar 38 Mackey MJ, Chilton CP, Gilling PJ, Fraundorfer M, Cresswell MD. The results of holmium laser resection of the prostate. Br J Urol 1998; 81: 518–9 10.1046/j.1464-410x.1998.00618.x CASPubMedWeb of Science®Google Scholar 39 Arai Y, Okubo K, Okada T, Maekawa S, Aoki Y, Maeda H. Interstitial laser coagulation for management of benign prostatic hyperplasia: A Japanese experience. J Urol 1998; 159: 1961–65 10.1016/S0022-5347(01)63210-5 CASPubMedWeb of Science®Google Scholar 40 Yakubu A, Barnes DG. Catheter-free endoscopic laser ablation of the prostate using a 1-size prostatic stent. J Urol 1998; 159: 1974–77 10.1016/S0022-5347(01)63214-2 CASPubMedWeb of Science®Google Scholar 41 Uchida T, Muramoto M, Kyunou H, Koshiba K. Clinical outcome of high-intensity focused ultrasound for treating benign prostatic hyperplasia: preliminary report. Urology 1998; 52: 66–71 10.1016/S0090-4295(98)00118-6 CASPubMedWeb of Science®Google Scholar 42 Makar AA, Thomas PJ, Fletcher MS, Harrison NW. Interstitial radiofrequency therapy of the prostate in the management of acute urinary retention. Br J Urol 1998; 81: 726–9 10.1046/j.1464-410x.1998.00624.x CASPubMedWeb of Science®Google Scholar 43 Desautel MG, Burney TL, Diaz PA, Austria A, Badlani GH. Outcome of Vaportrode transurethral vaporization of the prostate using pressure-flow urodynamic criteria. Urology 1998; 51: 1013–7 10.1016/S0090-4295(98)00102-2 CASPubMedWeb of Science®Google Scholar 44 Gesenberg A, Sintermann R. Management of benign prostatic hyperplasia in high risk patients: long-term experience with Memotherm stent. J Urol 1998; 160: 72–6 10.1016/S0022-5347(01)63034-9 CASPubMedWeb of Science®Google Scholar 45 Nickel JC for the Canadian PROSPECT Study Group. Placebo therapy of benign prostatic hyperplasia: a 25-month study. Br J Urol 1998; 81: 383–7 10.1046/j.1464-410x.1998.00554.x CASPubMedWeb of Science®Google Scholar 46 Gerber GS, Zagaja GP, Bales GT, Chodak GW, Contreras BA. Saw palmetto (Serenoa repens) in men with lower urinary tract symptoms: effects on urodynamic parameters and voiding symptoms. Urology 1998; 51: 1003–7 10.1016/S0090-4295(98)00143-5 CASPubMedWeb of Science®Google Scholar 47 Kirby RS. Terazosin in benign prostatic hyperplasia: effects on blood pressure in normotensive and hypertensive men. Br J Urol 1998; 82: 373–9 10.1046/j.1464-410X.1998.00747.x CASPubMedWeb of Science®Google Scholar 48 Michel MC, Mehlburger L, Bressel HU, Schumacher H, Schafers RF, Goepel M. Tamsulosin treatment of 19,365 patients with lower urinary tract symptoms: does co-morbidity alter tolerability? J Urol 1998; 160: 784–91 10.1016/S0022-5347(01)62787-3 CASPubMedWeb of Science®Google Scholar 49 Bolmsjö M, Sturesson C, Wagrell L, Andersson-engels S, Mattiasson A. Optimizing transurethral microwave thermotherapy: a model for studying power, blood flow, temperature variations and tissue destruction. Br J Urol 1998; 81: 811–6 10.1046/j.1464-410x.1998.00647.x CASPubMedWeb of Science®Google Scholar 50 Ronzoni G, De Vecchis M. Preservation of anterograde ejaculation after transurethral resection of both the prostate and bladder neck. Br J Urol 1998; 81: 830–3 10.1046/j.1464-410x.1998.00658.x CASPubMedWeb of Science®Google Scholar 51 Walden M, Dahlstrand C, Schäfer W, Pettersson S. How to select patients suitable for transurethral microwave thermotherapy: a systematic evaluation of potentially predictive variables. Br J Urol 1998; 81: 817–22 10.1046/j.1464-410x.1998.00656.x CASPubMedWeb of Science®Google Scholar 52 Jepsen JV, Leverson G, Bruskewitz RC. Variability in urinary flow rate and prostate volume; an investigation using the placebo arm of a drug trial. J Urol 1998; 160: 1689–94 10.1016/S0022-5347(01)62384-X CASPubMedWeb of Science®Google Scholar 53 Chakravarti A, MacDermott S. Transurethral resection of the prostate in the anticoagulated patient. Br J Urol 1998; 81: 520–2 10.1046/j.1464-410x.1998.00609.x CASPubMedWeb of Science®Google Scholar 54 Akalin Z, Mungan N, Basar H, Aydoganil L, Cengiz T. Transurethral resection of the prostate and laser prostatectomy under local anesthesia. Eur Urol 1998; 33: 202–5 10.1159/000019536 CASPubMedWeb of Science®Google Scholar 55 Vivien A, Lazard T, Rauss A, Laisne M, Bonnet F. Infection after transurethral resection of the prostate: variation among centers and correlation with a long-lasting surgical procedure. Eur Urol 1998; 33: 365–9 10.1159/000019617 CASPubMedWeb of Science®Google Scholar 56 Horton R. Surgical Research or comic opera: questions, but few answers. Lancet 1996; 347: 984 10.1016/S0140-6736(96)90137-3 CASPubMedWeb of Science®Google Scholar 57 McConnell JD, Barry MJ, Bruskewitz RC et al. eds. Benign Prostatic Hyperplasia: Diagnosis and Treatment. Clinical Practice Guideline. Rockville, Maryland: US Department of Health and Human Services, Agency for Health Care Policy and Research 1994 Google Scholar 58 Fowler FJ, Wennberg JE, Timothy RP et al. Symptom status and quality of life following prostatectomy. JAMA 1988; 259: 3018–22 PubMedWeb of Science®Google Scholar 59 Neal DE. The National Prostatectomy Audit. Br J Urol 1997; 79: 69–75 10.1111/j.1464-410X.1997.tb16924.x PubMedWeb of Science®Google Scholar 60 Reynard JM, Peters TJ, Lim C, Abrams P. The value of multiple free flow studies in men with lower urinary tract symptoms. Br J Urol 1996; 77: 813–8 10.1046/j.1464-410X.1996.00097.x CASPubMedWeb of Science®Google Scholar 61 Hansen BJ, Mortensen S, Mensink HJA et al. and the Alfech Study Group. Comparison of the Danish prostatic symptom score with the International Prostatic Symptom Score, the Madsen-Iversen and Boyarsky symptom indexes. Br J Urol 1998; 81: 62 10.1046/j.1464-410x.1998.00524.x PubMedWeb of Science®Google Scholar Citing Literature Volume85, Issues1March 2000Pages 46-53 ReferencesRelatedInformation
Referência(s)